111 related articles for article (PubMed ID: 3127078)
21. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
[TBL] [Abstract][Full Text] [Related]
22. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
Seydel W; Stang E; Roos N; Krause J
Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
[TBL] [Abstract][Full Text] [Related]
24. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
Einarsson M; Hggroth L; Mattsson C
Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
[TBL] [Abstract][Full Text] [Related]
25. Hepatic recognition and catabolism of serum glycoproteins.
Ashwell G; Steer CJ
JAMA; 1981 Nov; 246(20):2358-64. PubMed ID: 6271991
[No Abstract] [Full Text] [Related]
26. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
27. Clearance receptors for tissue-type plasminogen activator.
Camani C; Kruithof EK
Int J Hematol; 1994 Aug; 60(2):97-109. PubMed ID: 7948967
[TBL] [Abstract][Full Text] [Related]
28. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
29. The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamine.
Schlesinger PH; Rodman JS; Doebber TW; Stahl PD; Lee YC; Stowell CP; Kuhlenschmidt TB
Biochem J; 1980 Nov; 192(2):597-606. PubMed ID: 7236228
[TBL] [Abstract][Full Text] [Related]
30. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies to tissue-type plasminogen activator which prolong its clearance in vivo.
Reilly TM; Knabb RM; Chiu AT; Bradfute DL; Timmermans PB
Thromb Haemost; 1989 Apr; 61(2):259-61. PubMed ID: 2546285
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells.
Kuiper J; Otter M; Rijken DC; van Berkel TJ
J Biol Chem; 1988 Dec; 263(34):18220-4. PubMed ID: 3142872
[TBL] [Abstract][Full Text] [Related]
33. Augmented and sustained plasma concentrations after intramuscular injections of molecular variants and deglycosylated forms of tissue-type plasminogen activators.
Sobel BE; Sarnoff SJ; Nachowiak DA
Circulation; 1990 Apr; 81(4):1362-73. PubMed ID: 2107986
[TBL] [Abstract][Full Text] [Related]
34. Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.
Gawlitzek M; Estacio M; Fürch T; Kiss R
Biotechnol Bioeng; 2009 Aug; 103(6):1164-75. PubMed ID: 19418565
[TBL] [Abstract][Full Text] [Related]
35. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
Tanswell P; Heinzel G; Greischel A; Krause J
J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
[TBL] [Abstract][Full Text] [Related]
36. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line.
Parekh RB; Dwek RA; Rudd PM; Thomas JR; Rademacher TW; Warren T; Wun TC; Hebert B; Reitz B; Palmier M
Biochemistry; 1989 Sep; 28(19):7670-9. PubMed ID: 2514793
[TBL] [Abstract][Full Text] [Related]
37. Expression of endogenous receptors for neoglycoproteins, especially lectins, that allow fiber typing on formaldehyde-fixed, paraffin-embedded muscle biopsy specimens. A glycohistochemical, immunohistochemical, and glycobiochemical study.
Bardosi A; Dimitri T; Wosgien B; Gabius HJ
J Histochem Cytochem; 1989 Jul; 37(7):989-98. PubMed ID: 2732460
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
39. Effect of monensin on secretion of t-PA from melanoma (Bowes).
Fukao H; Ueshima S; Sakai T; Okada K; Matsuo O
Cell Struct Funct; 1989 Dec; 14(6):673-84. PubMed ID: 2516782
[TBL] [Abstract][Full Text] [Related]
40. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
Wing LR; Hawksworth GM; Bennett B; Booth NA
J Lab Clin Med; 1991 Feb; 117(2):109-14. PubMed ID: 1899689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
